Structure-activity relationships of αS1-casomorphin using AM1 calculations and molecular dynamics simulations

被引:3
作者
Wu, Yng-Ching
Lin, Jenn-Sen
Hwang, Chi-Chuan [1 ]
机构
[1] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan
[2] Natl United Univ, Dept Mech Engn, Miaoli 36003, Taiwan
关键词
D O I
10.1021/jp070477y
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
This paper investigates the structure-activity relationships of alpha(S1)-casomorphin (alpha(S1)-CM) using AM1 calculations and molecular dynamics (MD) simulations. Previous studies have shown that this peptide has remarkable opioid actions, and not only has a high affinity toward all three subtypes (kappa(1)-kappa(3)) of the kappa-opioid sites, but also inhibits the proliferation of the T47D human breast cancer cell line. The systematic conformer search performed by the AM1 calculations is based on the torsional angles of the Val(2)-Pro(3) (omega(2)) and Phe(4)-Pro(5) (omega(4)) amide bonds. The AM1 results reveal that the alpha(S1)-CM conformers strongly favor the cis/cis pair of the omega(2)/omega(4) amide bonds in the minimized energy state. Furthermore, the picture of these stable conformers is found to be a strong interaction of the coulomb's force between two terminuses. MD simulations are performed to investigate the features of both the structural stability and pharmacological activity of alpha(S1)-CM in aqueous solution. The simulation results reveal that the omega(2)/omega(4) amide bonds favor the cis/cis status in the stable state. Furthermore, the pharmacophoric distance between two aromatic rings is found to be 5.0 similar to 5.4A. The chi(1) rotamers of the Tyr and Phe residues show a preference for gauche (-) and trans, respectively. The side chain rotamers of alpha(S1)-CM are competed to those of other opioid ligands with a known potency and selectivity for delta- and mu-opioid receptors. Finally, we address a likely kappa pharmacophore model compared to the delta pharmacophore model.
引用
收藏
页码:7377 / 7383
页数:7
相关论文
共 47 条
[1]  
Aldrich J. V., 2003, BURGERS MED CHEM DRU, P329, DOI DOI 10.1002/0471266949.BMC100
[2]   MOLECULAR-DYNAMICS WITH COUPLING TO AN EXTERNAL BATH [J].
BERENDSEN, HJC ;
POSTMA, JPM ;
VANGUNSTEREN, WF ;
DINOLA, A ;
HAAK, JR .
JOURNAL OF CHEMICAL PHYSICS, 1984, 81 (08) :3684-3690
[3]   Effect of the peripherally selective κ-opioid agonist, asimadoline, on adjuvant arthritis [J].
Binder, W ;
Walker, JS .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (04) :647-654
[4]   NOVEL OPIOID PEPTIDES DERIVED FROM CASEIN (BETA-CASOMORPHINS) .1. ISOLATION FROM BOVINE CASEIN PEPTONE [J].
BRANTL, V ;
TESCHEMACHER, H ;
HENSCHEN, A ;
LOTTSPEICH, F .
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1979, 360 (09) :1211-1216
[5]   MORPHICEPTIN (NH4-TYR-PRO-PHE-PRO-CONH2) - A POTENT AND SPECIFIC AGONIST FOR MORPHINE (MU) RECEPTORS [J].
CHANG, KJ ;
KILLIAN, A ;
HAZUM, E ;
CUATRECASAS, P ;
CHANG, JK .
SCIENCE, 1981, 212 (4490) :75-77
[6]   EXPRESSION OF OPIOID-PEPTIDES IN CELLS AND STROMA OF HUMAN BREAST-CANCER AND ADENOFIBROMAS [J].
CHATIKHINE, VA ;
CHEVRIER, A ;
CHAUZY, C ;
DUVAL, C ;
DANJOU, J ;
GIRARD, N ;
DELPECH, B .
CANCER LETTERS, 1994, 77 (01) :51-56
[7]   PARTICLE MESH EWALD - AN N.LOG(N) METHOD FOR EWALD SUMS IN LARGE SYSTEMS [J].
DARDEN, T ;
YORK, D ;
PEDERSEN, L .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (12) :10089-10092
[8]   Peripherally restricted opioid agonists as novel analgesic agents [J].
DeHaven-Hudkins, DL ;
Dolle, RE .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (07) :743-757
[9]   NEUROENDOCRINE PRIMARY SMALL-CELL CARCINOMA OF THE BREAST - REPORT OF A CASE AND REVIEW OF THE LITERATURE [J].
FRANCOIS, A ;
CHATIKHINE, VA ;
CHEVALLIER, B ;
REN, GS ;
BERRY, M ;
CHEVRIER, A ;
DELPECH, B .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (02) :133-138
[10]  
GIARDINA G, 1995, FARMACO, V50, P405